Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe

Επιστημονική δημοσίευση - Άρθρο Περιοδικού uoadl:3110528 53 Αναγνώσεις

Μονάδα:
Ερευνητικό υλικό ΕΚΠΑ
Τίτλος:
Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Background: One out of ten newly diagnosed patients in Europe was infected with a virus carrying a drug resistant mutation. We analysed the patterns over time for transmitted drug resistance mutations (TDRM) using data from the European Spread program.Methods: Clinical, epidemiological and virological data from 4317 patients newly diagnosed with HIV-1 infection between 2002 and 2007 were analysed. Patients were enrolled using a pre-defined sampling strategy.Results: The overall prevalence of TDRM in this period was 8.9% (95% CI: 8.1-9.8). Interestingly, significant changes over time in TDRM caused by the different drug classes were found. Whereas nucleoside resistance mutations remained constant at 5%, a significant decline in protease inhibitors resistance mutations was observed, from 3.9% in 2002 to 1.6% in 2007 (p = 0.001). In contrast, resistance to non-nucleoside reverse transcriptase inhibitors (NNRTIs) doubled from 2.0% in 2002 to 4.1% in 2007 (p = 0.004) with 58% of viral strains carrying a K103N mutation. Phylogenetic analysis showed that these temporal changes could not be explained by large clusters of TDRM.Conclusion: During the years 2002 to 2007 transmitted resistance to NNRTI has doubled to 4% in Europe. The frequent use of NNRTI in first-line regimens and the clinical impact of NNRTI mutations warrants continued monitoring. © 2014 Frentz et al.; licensee BioMed Central Ltd.
Έτος δημοσίευσης:
2014
Συγγραφείς:
Frentz, D.
Van de Vijver, D.A.M.C.
Abecasis, A.B.
Albert, J.
Hamouda, O.
Jørgensen, L.B.
Kücherer, C.
Struck, D.
Schmit, J.-C.
Vercauteren, J.
Åsjö, B.
Balotta, C.
Beshkov, D.
Camacho, R.J.
Clotet, B.
Coughlan, S.
Griskevicius, A.
Grossman, Z.
Horban, A.
Kolupajeva, T.
Korn, K.
Kostrikis, L.G.
Liitsola, K.
Linka, M.
Nielsen, C.
Otelea, D.
Paraskevis, D.
Paredes, R.
Poljak, M.
Puchhammer-Stöckl, E.
Sönnerborg, A.
Stanekova, D.
Stanojevic, M.
Van Wijngaerden, E.
Wensing, A.M.J.
Boucher, C.A.B.
Puchhammer-Stockl, E.
Sarcletti, M.
Schmied, B.
Geit, M.
Balluch, G.
Vandamme, A.-M.
Vercauteren, J.
Derdelinckx, I.
Sasse, A.
Bogaert, M.
Ceunen, H.
De Roo, A.
De Wit, S.
Echahidi, F.
Fransen, K.
Goffard, J.-C.
Goubau, P.
Goudeseune, E.
Yombi, J.-C.
Lacor, P.
Liesnard, C.
Moutschen, M.
Pierard, D.
Rens, R.
Schrooten, Y.
Vaira, D.
Vandekerckhove, L.P.R.
Van den Heuvel, A.
Van Der Gucht, B.
Van Ranst, M.
Vandercam, B.
Vekemans, M.
Verhofstede, C.
Clumeck, N.
Van Laethem, K.
Demetriades, I.
Kousiappa, I.
Demetriou, V.
Hezka, J.
Bruckova, M.
Linka, M.
Machala, L.
Nielsen, C.
Jørgensen, L.B.
Gerstoft, J.
Mathiesen, L.
Pedersen, C.
Nielsen, H.
Laursen, A.
Kvinesdal, B.
Salminen, M.
Ristola, M.
Liitsola, K.
Suni, J.
Sutinen, J.
Korn, K.
Kücherer, C.
Berg, T.
Braun, P.
Poggensee, G.
Däumer, M.
Eberle, J.
Heiken, H.
Kaiser, R.
Knechten, H.
Müller, H.
Neifer, S.
Schmidt, B.
Walter, H.
Gunsenheimer-Bartmeyer, B.
Harrer, T.
Paraskevis, D.
Hatzakis, A.
Magiorkinis, E.
Hatzitheodorou, E.
Haida, C.
Zavitsanou, A.
Magiorkinis, G.
Lazanas, M.
Chini, M.
Magafas, N.
Tsogas, N.
Paparizos, V.
Kourkounti, S.
Antoniadou, A.
Papadopoulos, A.
Panagopoulos, P.
Poulakou, G.
Sakka, V.
Chryssos, G.
Drimis, S.
Gargalianos, P.
Lelekis, M.
Chilomenos, G.
Psichogiou, M.
Daikos, G.L.
Panos, G.
Haratsis, G.
Kordossis, T.
Kontos, A.
Koratzanis, G.
Theodoridou, M.
Mostrou, G.
Spoulou, V.
Coughlan, S.
De Gascun, C.
Byrne, C.
Duffy, M.
Bergin, C.
Reidy, D.
Farrell, G.
Lambert, J.
O'Connor, E.
Rochford, A.
Low, J.
Coakely, P.
O'Dea, S.
Hall, W.
Grossman, Z.
Levi, I.
Chemtob, D.
Balotta, C.
Riva, C.
Mussini, C.
Caramma, I.
Capetti, A.
Colombo, M.C.
Rossi, C.
Prati, F.
Tramuto, F.
Vitale, F.
Ciccozzi, M.
Angarano, G.
Rezza, G.
Schmit, J.C.
Struck, D.
Hemmer, R.
Arendt, V.
Staub, T.
Schneider, F.
Roman, F.
Wensing, A.M.J.
Boucher, C.A.B.
van Kessel, A.
van Bentum, P.H.M.
Brinkman, K.
op de Coul, E.L.
van der Ende, M.E.
Hoepelman, I.
van Kasteren, M.
Juttmann, J.
Kuipers, M.
Langebeek, N.
Richter, C.
Santegoets, R.
Schrijnders-Gudde, L.
Schuurman, R.
van de Ven, B.J.M.
Åsjö, B.
Ormaasen, V.
Aavitsland, P.
Horban, A.
Stanczak, J.J.
Stanczak, G.P.
Firlag-Burkacka, E.
Wiercinska-Drapalo, A.
Jablonowska, E.
Malolepsza, E.
Leszczyszyn-Pynka, M.
Szata, W.
Camacho, R.
Palma, C.
Borges, F.
Paixão, T.
Duque, V.
Araújo, F.
Jevtovic, D.
Salemovic, D.
Stanekova, D.
Habekova, M.
Mokras, M.
Truska, P.
Poljak, M.
Lunar, M.
Babic, D.
Tomazic, J.
Vidmar, L.
Vovko, T.
Karner, P.
Clotet, B.
Domingo, P.
Galindo, M.J.
Miralles, C.
del Pozo, M.A.
Ribera, E.
Iribarren, J.A.
Ruiz, L.
de la Torre, J.
Vidal, F.
Garcia, F.
Paredes, R.
Albert, J.
Heidarian, A.
Aperia-Peipke, K.
Axelsson, M.
Mild, M.
Karlsson, A.
Sönnerborg, A.
Thalme, A.
Navér, L.
Bratt, G.
Karlsson, A.
Blaxhult, A.
Gisslén, M.
Svennerholm, B.
Bergbrant, I.
Björkman, P.
Säll, C.
Mellgren, Å.
Lindholm, A.
Kuylenstierna, N.
Montelius, R.
Azimi, F.
Johansson, B.
Carlsson, M.
Johansson, E.
Ljungberg, B.
Ekvall, H.
Strand, A.
Mäkitalo, S.
öberg, S.
Holmblad, P.
Höfer, M.
Holmberg, H.
Josefson, P.
Ryding, U.
on behalf of the SPREAD Programme
Περιοδικό:
BMC Infectious Diseases
Εκδότης:
BioMed Central Ltd.
Τόμος:
14
Αριθμός / τεύχος:
1
Λέξεις-κλειδιά:
nonnucleoside reverse transcriptase inhibitor; proteinase inhibitor, adult; Article; controlled study; Europe; female; human; Human immunodeficiency virus 1 infection; major clinical study; male; molecular phylogeny; nonhuman; nucleotide sequence; risk factor; unindexed sequence; virus mutation; virus resistance; virus strain; virus transmission, Adult; Anti-HIV Agents; Drug Resistance, Viral; Europe; Female; Genotype; HIV Infections; HIV-1; Humans; Male; Mutation; Phylogeny; Prevalence
Επίσημο URL (Εκδότης):
DOI:
10.1186/1471-2334-14-407
Το ψηφιακό υλικό του τεκμηρίου δεν είναι διαθέσιμο.